Barclays
BNGO icon

Barclays’s Bionano Genomics BNGO Stock Holding History

Barclays’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$8 – 5273
2025
Q1 		$8 Hold
3
– – ﹤0.01% 5183
2024
Q4 		$58 Hold
3
– – ﹤0.01% 5194
2024
Q3 		$91 Hold
3
– – ﹤0.01% 5185
2024
Q2 		$136 Hold
3
– – ﹤0.01% 4745
2024
Q1 		$222 Hold
3
– – ﹤0.01% 4983
2023
Q4 		$378 Buy
+3
New +$313 ﹤0.01% 5140
2023
Q3 		– Sell
-3
Closed -$1.22K – 4605
2023
Q2 		$1.22K Sell
3
-253
-99% -$114K ﹤0.01% 4354
2023
Q1 		$171K Buy
256
+119
+87% +$106K ﹤0.01% 3886
2022
Q4 		$120K Buy
137
+113
+471% +$142K ﹤0.01% 4123
2022
Q3 		$27K Sell
24
-4
-14% -$5.29K ﹤0.01% 3967
2022
Q2 		$23K Sell
28
-57
-67% -$58.6K ﹤0.01% 4334
2022
Q1 		$130K Sell
85
-509
-86% -$687K ﹤0.01% 3667
2021
Q4 		$1.06M Buy
594
+398
+203% +$1.06M ﹤0.01% 2791
2021
Q3 		$645K Buy
196
+101
+106% +$353K ﹤0.01% 3045
2021
Q2 		$417K Buy
95
+91
+2,275% +$359K ﹤0.01% 3175
2021
Q1 		$17K Buy
+4
New +$22.6K ﹤0.01% 4392
2020
Q4 		– Sell
-1
Closed -$374 – 4891
2020
Q3 		$0 Sell
1
-199
-100% -$77.2K ﹤0.01% 5229
2020
Q2 		$61K Buy
+200
New +$50.2K ﹤0.01% 4834

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return

Barclays's BNGO Position: Q2 2025 in Review

Barclays sold out of Bionano Genomics (BNGO) in Q2 2025, closing a stake of 3 shares — an estimated $8 sold.

Barclays first reported a position in BNGO in Q2 2020 and held it in 18 quarters. The position peaked at $1.06M in Q4 2021. 29 funds tracked by Wall St. Rank hold BNGO as of Q2 2025.

  • Barclays reported no remaining Bionano Genomics position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 3 Bionano Genomics shares in Q2 2025, an estimated $8.
  • Barclays first reported a position in Bionano Genomics in Q2 2020 and held it in 18 quarters.
  • Barclays's Bionano Genomics position peaked at $1.06M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.